Issue 10- Oct 2023
New CEC: Venlafaxine modified release tablets; Deprescribing and social media campaigns; Deprescribe: Opioids for chronic pain; Deprescribe: Bath and shower products; NICE Guidance (Recently Published); Managed Entry Decisions
New CEC: Venlafaxine modified release tablets; Deprescribing and social media campaigns; Deprescribe: Opioids for chronic pain; Deprescribe: Bath and shower products; NICE Guidance (Recently Published); Managed Entry Decisions